Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

OVID is expected to report earnings to rise 15.50% to -16 cents per share on August 18

Ovid Therapeutics OVID Stock Earnings Reports

Q2'25

Est.

$-0.16

Q1'25

Est.

$-0.14

Q4'24

Beat

by $0.04

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.34

The last earnings report on May 13 showed earnings per share of -14 cents, meeting the estimate of -14 cents. With 1.80M shares outstanding, the current market capitalization sits at 24.39M.

View a ticker or compare two or three

Compare

OVID